JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.57B |
| 2 |
Occidental Petroleum
OXY
|
+$966M |
| 3 |
Meta Platforms (Facebook)
META
|
+$738M |
| 4 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$661M |
| 5 |
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
|
+$625M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Europe ETF
VGK
|
+$1.54B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$903M |
| 3 |
KMP
KINDER MORGAN ENER PNTRS L.P.
KMP
|
+$865M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$775M |
| 5 |
Freeport-McMoran
FCX
|
+$543M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.23% |
| 2 | Financials | 13.31% |
| 3 | Healthcare | 10.98% |
| 4 | Technology | 10.39% |
| 5 | Industrials | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
VISN
2901
PUT
Vistance Networks Inc
VISN
$1.43B
| $1.66M | ﹤0.01% |
72,800
-211,700
| -74% | -$4.73M |
2014 Q3
1 quarter
|
|
2902
First Trust Developed Markets ex-US AlphaDEX Fund
FDT
$1.37B
| $1.66M | ﹤0.01% |
35,104
+20,717
| +144% | +$993K |
2014 Q3
1 quarter
|
|
|
SGMO
2903
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.66M | ﹤0.01% |
+108,863
| New | +$1.32M |
2014 Q4
0 quarters
|
|
2904
CALL
Teva Pharmaceutical Industries Limited
TEVA
$46.3B
| $1.66M | ﹤0.01% |
+28,800
| New | +$1.6M |
2014 Q4
0 quarters
|
|
|
OAK
2905
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| $1.66M | ﹤0.01% |
31,964
-463
| -1% | -$22.4K |
2013 Q2
6 quarters
|
|
|
EBIX
2906
DELISTED
Ebix Inc
EBIX
| $1.65M | ﹤0.01% |
97,356
+85,469
| +719% | +$1.31M |
2014 Q2
2 quarters
|
|
|
FCE.A
2907
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $1.65M | ﹤0.01% |
77,582
-6,516
| -8% | -$135K |
2013 Q2
6 quarters
|
|
2908
Bio-Rad Laboratories Class A
BIO
$10.2B
| $1.65M | ﹤0.01% |
13,658
-39,581
| -74% | -$4.56M |
2013 Q2
6 quarters
|
|
|
MRTX
2909
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.65M | ﹤0.01% |
88,800
-4,325
| -5% | -$72.9K |
2014 Q3
1 quarter
|
|
|
DBD
2910
DELISTED
Diebold Nixdorf Incorporated
DBD
| $1.64M | ﹤0.01% |
47,219
-7,967
| -14% | -$281K |
2013 Q2
6 quarters
|
|
|
RDUS
2911
DELISTED
Radius Recycling
RDUS
| $1.63M | ﹤0.01% |
72,348
+10,675
| +17% | +$245K |
2013 Q2
6 quarters
|
|
2912
Vanguard Russell 2000 ETF
VTWO
$16.6B
| $1.63M | ﹤0.01% |
34,176
-2,548
| -7% | -$117K |
2013 Q2
6 quarters
|
|
|
INVN
2913
PUT
DELISTED
Invensense Inc
INVN
| $1.63M | ﹤0.01% |
+100,000
| New | +$1.68M |
2014 Q4
0 quarters
|
|
|
PHH
2914
DELISTED
PHH Corporation
PHH
| $1.62M | ﹤0.01% |
67,712
-33,498
| -33% | -$779K |
2013 Q2
6 quarters
|
|
|
ENLC
2915
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $1.61M | ﹤0.01% |
45,320
+10,328
| +30% | +$371K |
2013 Q2
6 quarters
|
|
2916
First Business Financial Services
FBIZ
$591M
| $1.61M | ﹤0.01% |
67,100
| – | – |
2014 Q2
2 quarters
|
|
2917
Genesco
GCO
$386M
| $1.6M | ﹤0.01% |
20,909
-1,756
| -8% | -$133K |
2013 Q2
6 quarters
|
|
|
PMC
2918
DELISTED
PharMerica Corporation
PMC
| $1.6M | ﹤0.01% |
77,391
-432,117
| -85% | -$10.3M |
2013 Q2
6 quarters
|
|
2919
CALL
Eli Lilly
LLY
$1.02T
| $1.6M | ﹤0.01% |
23,200
-20,900
| -47% | -$1.41M |
2014 Q3
1 quarter
|
|
2920
CALL
CVS Health
CVS
$111B
| $1.6M | ﹤0.01% |
16,600
-11,300
| -41% | -$996K |
2014 Q3
1 quarter
|
|
2921
First Trust Europe AlphaDEX Fund
FEP
$503M
| $1.59M | ﹤0.01% |
54,314
-23,176
| -30% | -$690K |
2013 Q2
6 quarters
|
|
2922
iShares MSCI EAFE Growth ETF
EFG
$15.2B
| $1.59M | ﹤0.01% |
24,160
+20,369
| +537% | +$1.36M |
2013 Q2
6 quarters
|
|
2923
Magnite
MGNI
$3.58B
| $1.59M | ﹤0.01% |
98,350
+4,275
| +5% | +$55.2K |
2014 Q2
2 quarters
|
|
|
ZEP
2924
DELISTED
ZEP INC COM STK (DE)
ZEP
| $1.59M | ﹤0.01% |
104,694
-5,500
| -5% | -$81.3K |
2013 Q2
6 quarters
|
|
|
MCF
2925
DELISTED
Contango Oil & Gas Co.
MCF
| $1.58M | ﹤0.01% |
54,179
+766
| +1% | +$25.8K |
2013 Q2
6 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2014 Portfolio in Review
As of Q4 2014, JP Morgan Chase held 4,595 positions worth $437B, up 3.7% from $422B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2014 filing shows 424 new, 1,620 increased, 1,864 reduced and 391 closed positions. Its largest new stake was TRIBUNE MEDIA COMPANY CLASS A: 10,171,721 shares worth $608M. The largest sale was Vanguard FTSE Europe ETF, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2014 buy was TRIBUNE MEDIA COMPANY CLASS A: 10,171,721 shares worth $608M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $2.57B increase.
- JP Morgan Chase's biggest Q4 2014 reduction was Vanguard FTSE Europe ETF, cutting an estimated $1.54B.
- JP Morgan Chase fully exited KINDER MORGAN ENER PNTRS L.P. in Q4 2014, selling an estimated $865M.
- JP Morgan Chase's ten largest holdings make up 16% of its $437B portfolio in Q4 2014.
- JP Morgan Chase opened 424 new positions and closed 391 in Q4 2014.
- JP Morgan Chase's portfolio value rose 3.7% quarter-over-quarter to $437B.
Based on JP Morgan Chase's 13F filing for Q4 2014, filed 13 Feb 2015.